FMRFamide, a putative endogenous opiate antagonist: evidence from suppression of defeat-induced analgesia and feeding in mice.
Social conflict and defeat in mice leads to an activation of endogenous opiate systems. The effects of intracerebroventricular administration of the peptide FMRFamide (Phe-Met-Arg-Phe-NH2) and the opiate antagonist naloxone, on aggressive encounters, defeat-induced analgesia and defeat-induced feeding were examined in male mice. Both substances reduced the number of bites required to cause defeat in subordinate mice during aggressive encounters, as well as suppressing the subsequent defeat-induced analgesia. Administration of FMRFamide or naloxone also reduced defeat-induced feeding. These results indicate that FMRFamide (or FMRFamide-like neuropeptides) may function as endogenous opioid antagonists.
D000698:Analgesia; D000818:Animals; D003220:Conflict, Psychological; D019835:FMRFamide; D005247:Feeding Behavior / Q000187:drug effects*; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology*; D013997:Time Factors
D009842:Oligopeptides; D009270:Naloxone; D019835:FMRFamide